Buscar
Mostrando ítems 1-10 de 480
Review of adverse cutaneous reactions of pharmacologic interventions for coronavirus disease 2019 (COVID-19): a guide for the dermatologist
The new coronavirus SARS-CoV-2 is associated with a wide variety of cutaneous manifestations. While new skin manifestations caused by COVID-19 are continuously being described, other cutaneous entities should also be ...
How far are we from predicting multi-drug interactions during treatment for COVID-19 infection?
(WILEY, 2022)
Seriously ill patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and hospitalized in intensive care units (ICUs) are commonly given a combination of drugs, a process known as multi-drug ...
Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China
The fight against the novel coronavirus pneumonia (namely COVID-19) that seriously harms human health is a
common task for all mankind. Currently, development of drugs against the novel coronavirus (namely SARSCoV-2) is ...
Can drug repurposing strategies be the solution to the COVID-19 crisis?
(Taylor & Francis Ltd, 2020-12)
Introduction: The current COVID-19 pandemic has resulted in disastrous human and economic costs, mainly due to the absence of specific treatments to ameliorate the effects of this emerging viral disease. Complementary to ...
Combating COVID-19: The role of drug repurposing and medicinal plants
Background:A novel corona virus-2 disease has spread to 213 countries and territories across the globe.
The corona pandemic has claimed more than 548,934 deaths worldwide till the evening of 8
th of July 2020
and the ...
COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz., 2020)
Lopinavir/ritonavir: repurposing an old drug for HIV infection in COVID-19 treatment
Currently, there is no specific antiviral treatment for COVID-19. However, drugs previously
developed to treat other viral infections are being tested to verify if they might also be effective
against SARS-CoV-2, the ...
Drug repurposing and cytokine management in response to COVID-19: a re- view
Coronavirus disease 2019 (COVID-19), the infectious disease caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an aggressive disease that attacks
the respiratory tract and has a higher fatality ...
Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment
Background: SARS-CoV-2 has the Spike glycoprotein (S) which is crucial in attachment with host receptor and cell
entry leading to COVID-19 infection. The current study was conducted to explore drugs against Receptor ...